Group One Trading
PDSB icon

Group One Trading’s PDS Biotechnology PDSB Stock Holding History

Group One Trading’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.14K Hold
3,567
– – ﹤0.01% 6901
2026
Q1 		$2.16K Sell
3,567
-355
-9% -$267 ﹤0.01% 7028
2025
Q4 		$3.02K Buy
+3,922
New +$3.54K ﹤0.01% 7399
2024
Q3 		– Sell
-8,481
Closed -$28.3K – 7185
2024
Q2 		$24.8K Sell
8,481
-21,975
-72% -$70.3K ﹤0.01% 5066
2024
Q1 		$121K Sell
30,456
-22,686
-43% -$117K ﹤0.01% 3997
2023
Q4 		$264K Buy
53,142
+11,994
+29% +$59.6K ﹤0.01% 3610
2023
Q3 		$208K Buy
41,148
+5,740
+16% +$31.4K ﹤0.01% 3769
2023
Q2 		$178K Buy
35,408
+30,548
+629% +$200K ﹤0.01% 4065
2023
Q1 		$29.9K Sell
4,860
-4,839
-50% -$39.6K ﹤0.01% 5242
2022
Q4 		$128K Buy
9,699
+9,599
+9,599% +$67.7K ﹤0.01% 4217
2022
Q3 		$0 Sell
100
-300
-75% -$1.27K ﹤0.01% 8060
2022
Q2 		$1K Hold
400
– – ﹤0.01% 7603
2022
Q1 		$2K Buy
400
+100
+33% +$621 ﹤0.01% 7742
2021
Q4 		$2K Buy
300
+100
+50% +$1.08K ﹤0.01% 7892
2021
Q3 		$3K Buy
+200
New +$2.49K ﹤0.01% 7879
2021
Q2 		– Sell
-25
Closed -$195 – 8468
2021
Q1 		$0 Hold
25
– – ﹤0.01% 7916
2020
Q4 		$0 Hold
25
– – ﹤0.01% 6868
2020
Q3 		$0 Hold
25
– – ﹤0.01% 6436
2020
Q2 		$0 Hold
25
– – ﹤0.01% 6081
2020
Q1 		$0 Hold
25
– – ﹤0.01% 5623
2019
Q4 		$0 Hold
25
– – ﹤0.01% 5495
2019
Q3 		$0 Hold
25
– – ﹤0.01% 5439
2019
Q2 		$0 Hold
25
– – ﹤0.01% 5289
2019
Q1 		$0 Hold
25
– – ﹤0.01% 5229
2018
Q4 		$0 Hold
25
– – ﹤0.01% 5270
2018
Q3 		$0 Sell
25
-25
-50% -$449 ﹤0.01% 5513
2018
Q2 		$1K Sell
50
-200
-80% -$4.17K ﹤0.01% 4996
2018
Q1 		$6K Buy
+250
New +$67.2K ﹤0.01% 4476

Other funds holding PDSB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
MCM
Militia Capital Management Austin, Texas $3.37B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Group One Trading's PDSB Position: Q2 2026 in Review

Group One Trading held its PDS Biotechnology (PDSB) position steady in Q2 2026 at 3,567 shares worth $3.14K. The position accounts for ﹤0.01% of the portfolio, ranked #6901.

Group One Trading first reported a position in PDSB in Q1 2018 and has held it in 28 quarters since. The position peaked at $264K in Q4 2023. 52 funds tracked by Wall St. Rank hold PDSB as of Q2 2026.

  • Group One Trading held 3,567 shares of PDS Biotechnology worth $3.14K as of Q2 2026.
  • Group One Trading left its PDS Biotechnology share count unchanged in Q2 2026.
  • PDS Biotechnology made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6901 holding.
  • Group One Trading first reported a position in PDS Biotechnology in Q1 2018 and has held it in 28 quarters since.
  • Group One Trading's PDS Biotechnology position peaked at $264K in Q4 2023.
  • 52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.